Intellia Therapeutics, Inc. · NASDAQ:NTLA
Leonard John M sold 22,675 Intellia Therapeutics, Inc. shares (Form 4)
Traded Aug 20 to Aug 21, 2026 · Filed Aug 24, 2026
From Aug 20 to Aug 21, 2026, Leonard John M (Director, President and CEO) sold 22,675 Intellia Therapeutics, Inc. shares at an average US$12.65 for US$287K under a trading plan, leaving 1,147,064 shares. Filed Aug 24, 2026 (Form 4).
- Sold
- 22,675 shares
- Price
- US$12.65 average (US$12.60 to US$13.00)
- Value
- US$287K
- Holding after
- 1,147,064 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | Sale | 19,890 | US$12.60 | 1,149,849 | Direct |
| Aug 21, 2026 | Common Stock | Sale | 2,785 | US$13.00 | 1,147,064 | Direct |